Image-Guided Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer: Preliminary Clinical Results (Q53274295)

12 May 2018

title

Image-Guided Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer: Preliminary Clinical Results (English)

1 reference

https://api.crossref.org/works/10.1177/153303461000900505

adaptive radiation therapy

6 July 2024

main subject

0 references

1 reference

Giampaolo Bolzicco

1

1 reference

12 May 2018

Maria Silvia Favretto

2

1 reference

12 May 2018

Enrico Scremin

3

1 reference

12 May 2018

Carmelo Tambone

4

1 reference

12 May 2018

Andrea Tasca

5

1 reference

12 May 2018

Rosabianca Guglielmi

6

1 reference

12 May 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20815418

6 July 2024

publication date

1 October 2010

1 reference

12 May 2018

full work available at URL

http://journals.sagepub.com/doi/pdf/10.1177/153303461000900505

1 reference

https://api.crossref.org/works/10.1177/153303461000900505

Technology in Cancer Research and Treatment

6 July 2024

published in

1 reference

12 May 2018

volume

9

1 reference

12 May 2018

issue

5

1 reference

12 May 2018

page(s)

473-477

1 reference

12 May 2018

Evolution of computerized radiotherapy in radiation oncology: potential problems and solutions

cites work

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900505

From IMRT to IGRT: frontierland or neverland?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900505

Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900505

Is alpha/beta for prostate tumors really low?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900505

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900505

CyberKnife radiotherapy for localized prostate cancer: rationale and technical feasibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900505

Stereotactic body radiotherapy: an emerging treatment approach for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900505

Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900505

Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900505

Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900505

What hypofractionated protocols should be tested for prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900505

Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900505

Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900505

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303461000900505

Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience

21 January 2018

8

1 reference

https://api.crossref.org/works/10.1177/153303461000900505

Toward optimal external-beam fractionation for prostate cancer

6 July 2024

13

1 reference

https://api.crossref.org/works/10.1177/153303461000900505

Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue

6 July 2024

15

1 reference

https://api.crossref.org/works/10.1177/153303461000900505

6 July 2024

Identifiers

1 reference

12 May 2018

1 reference

12 May 2018